Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemofiltration | 3 | 2017 | 15 | 1.880 |
Why?
|
| Brain Injuries | 3 | 2017 | 127 | 1.650 |
Why?
|
| Renal Replacement Therapy | 3 | 2017 | 20 | 1.400 |
Why?
|
| Vasospasm, Intracranial | 1 | 2021 | 16 | 0.880 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 52 | 0.850 |
Why?
|
| Brain Ischemia | 2 | 2021 | 298 | 0.830 |
Why?
|
| Encephalocele | 1 | 2015 | 13 | 0.570 |
Why?
|
| Brain Edema | 1 | 2015 | 22 | 0.570 |
Why?
|
| Thrombophilia | 1 | 2015 | 16 | 0.570 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 11 | 0.570 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 9 | 0.570 |
Why?
|
| Decision Making | 1 | 2017 | 319 | 0.530 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 106 | 0.520 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 103 | 0.500 |
Why?
|
| Stroke | 1 | 2015 | 870 | 0.320 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 53 | 0.220 |
Why?
|
| Oncogene Proteins | 2 | 2013 | 45 | 0.210 |
Why?
|
| Hedgehog Proteins | 2 | 2013 | 112 | 0.200 |
Why?
|
| Bed Rest | 1 | 2019 | 9 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2022 | 331 | 0.190 |
Why?
|
| Trans-Activators | 2 | 2013 | 308 | 0.180 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 151 | 0.180 |
Why?
|
| Zebrafish | 2 | 2013 | 300 | 0.170 |
Why?
|
| Middle Aged | 4 | 2019 | 13480 | 0.160 |
Why?
|
| Humans | 7 | 2022 | 49437 | 0.160 |
Why?
|
| Renal Dialysis | 1 | 2017 | 167 | 0.150 |
Why?
|
| Adolescent | 2 | 2017 | 5350 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2015 | 97 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 963 | 0.140 |
Why?
|
| Aged | 3 | 2019 | 10883 | 0.130 |
Why?
|
| Male | 4 | 2019 | 23189 | 0.130 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 32 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 13261 | 0.120 |
Why?
|
| Female | 4 | 2019 | 26359 | 0.120 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 150 | 0.110 |
Why?
|
| Prevalence | 1 | 2015 | 1116 | 0.110 |
Why?
|
| Endocrine Cells | 1 | 2008 | 10 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2019 | 4487 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2008 | 59 | 0.090 |
Why?
|
| Young Adult | 1 | 2017 | 3656 | 0.090 |
Why?
|
| Risk Factors | 1 | 2015 | 4255 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 2080 | 0.070 |
Why?
|
| Glasgow Coma Scale | 1 | 2022 | 29 | 0.060 |
Why?
|
| Zinc Finger Protein GLI1 | 2 | 2013 | 32 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 2 | 2013 | 168 | 0.050 |
Why?
|
| Prognosis | 1 | 2022 | 1253 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2022 | 725 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 70 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 3186 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 288 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 335 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2013 | 2750 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3834 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4227 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 665 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2008 | 10 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2008 | 25 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 605 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2008 | 30 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 78 | 0.020 |
Why?
|
| Animals | 2 | 2013 | 17986 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1242 | 0.020 |
Why?
|
| Mutation | 1 | 2008 | 2262 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 1450 | 0.010 |
Why?
|